DOI QR코드

DOI QR Code

Human Cases of Fascioliasis in Fujian Province, China

  • Ai, Lin (National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health and Family Planning Commission) ;
  • Cai, Yu-Chun (National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health and Family Planning Commission) ;
  • Lu, Yan (National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health and Family Planning Commission) ;
  • Chen, Jia-Xu (National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health and Family Planning Commission) ;
  • Chen, Shao-Hong (National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health and Family Planning Commission)
  • Received : 2016.11.12
  • Accepted : 2017.01.15
  • Published : 2017.02.28

Abstract

Fascioliasis is a foodborne zoonotic parasitic disease. We report 4 cases occurring in the same family, in whom diagnosis of acute fascioliasis was established after series of tests. One case was hospitalized with fever, eosinophilia, and hepatic lesions. MRI showed hypodense changes in both liver lobes. The remaining 3 cases presented with the symptom of stomachache only. Stool analysis was positive for Fasciola eggs in 2 adult patients. The immunological test and molecular identification of eggs were confirmed at the National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China. The results of serological detection were positive in all the 4 patients. DNA sequencing of PCR products of the eggs demonstrated 100% homology with ITS and cox1 of Fasciola hepatica. The conditions of the patients were not improved by broad-spectrum anti-parasitic drugs until administration of triclabendazole.

Keywords

References

  1. Mas-Coma S, Bargues MD, Valero MA. Fascioliasis and other plant-borne trematode zoonoses. Int J Parasitol 2005; 35: 1255-1278. https://doi.org/10.1016/j.ijpara.2005.07.010
  2. Mas-Coma S, Valero MA, Bargues MD. Fascioliasis. Adv Exp Med Biol 2014; 766: 77-114.
  3. Mas-Coma S, Valero MA, Bargues MD. Chapter 2. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol 2009; 69: 41-146.
  4. Kim AJ, Choi CH, Choi SK, Shin YW, Park YK, Kim L, Choi SJ, Han JY, Kim JM, Chu YC, Park IS. Ectopic human Fasciola hepatica infection by an adult worm in the mesocolon. Korean J Parasitol 2015; 53: 725-730. https://doi.org/10.3347/kjp.2015.53.6.725
  5. Qureshi AW, Tanveer A, Mas-Coma S. Epidemiological analysis of human fascioliasis in northeastern Punjab, Pakistan. Acta Trop 2016; 156: 157-164. https://doi.org/10.1016/j.actatropica.2015.12.023
  6. Furst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 210-221. https://doi.org/10.1016/S1473-3099(11)70294-8
  7. Mas-Coma S, Agramunt VH, Valero MA. Neurological and ocular fascioliasis in humans. Adv Parasitol 2014; 84: 27-149.
  8. Valero MA, Bargues MD, Khoubbane M, Artigas P, Quesada C, Berinde L, Ubeira FM, Mezo MM, Hernandez JL, Agramunt VH, Mas-Coma S. Higher physiopathogenicity by Fasciola gigantica than by the genetically close F. hepatica: experimental long-term follow-up of biochemical markers. Trans R Soc Trop Med Hyg 2016; 110: 55-66. https://doi.org/10.1093/trstmh/trv110
  9. Dalton JP, Robinson MW, Mulcahy G, O'Neill SM, Donnelly S. Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development. Vet Parasitol 2013; 195: 272-285. https://doi.org/10.1016/j.vetpar.2013.04.008
  10. Girones N, Valero MA, Garcia-Bodelon MA, Chico-Calero I, Punzon C, Fresno M, Mas-Coma S. Immune suppression in advanced chronic fascioliasis: an experimental study in a rat model. J Infect Dis 2007; 195: 1504-1512. https://doi.org/10.1086/514822
  11. World Health Organization. Fact sheet on fascioliasis. In Action Against Worms. World Health Organization, Geneva, Switzerland. Newsletter 2008; 10: 1-8.
  12. Gil LC, Diaz A, Rueda C, Martinez C, Castillo D, Apt W. Resistant human fasciolasis: report of four patients. Rev Med Chil 2014; 142: 1330-1333 (in Spanish). https://doi.org/10.4067/S0034-98872014001000014
  13. Chen JZ, Xu F, Wu RZ, Guo RN, Xing DZ, Huang DL, Li SW, Lin SX, Huang JM, Liu YR, Chen DY. Human infections with Fasciola hepatica and Fasciola gigantica in Hainan province. Chin J Parasitol Parasit Dis 1994; 12: 243 (in Chinese).
  14. Fan D, Li P, Sun H, Wang ZH, She B. CT features of liver abscesses caused by the Fasciola hepatica infection. Chin J Radiol 2006 ; 40: 191-194 (in Chinese).
  15. Huang ZM, Xing LY, Fan B, Zhao W, Fan ZH. Report on a patient infected with Fasciola hepatica. Chin Trop Med 2006; 16: 1624 (in Chinese).
  16. Huang ZM, Xing LY, Li LJ, Fan B. Two cases of fascioliasis hepatica. Parasit Infect Dis 2009 ; 7: 172 (in Chinese).
  17. Chen JX, Chen MX, Ai L, Xu XN, Jiao JM, Zhu TJ, Su HY, Zang W, Luo JJ, Guo YH, Lv S, Zhou XN. An Outbreak of human fascioliasis gigantica in Southwest China. PLoS One 2013; 8: e71520. https://doi.org/10.1371/journal.pone.0071520
  18. Chen MX, Chen SH, Hu W, Li J, Ai L, Chen JX. Parasitological and molecular detection on a young man of human fasciolosis diagnosed in Guizhou, China. Trop Biomed 2017 (in press).
  19. Valero MA, Periago MV, Perez-Crespo I, Rodriguez E, Perteguer MJ, Garate T, Gonzalez-Barbera EM, Mas-Coma S. Assessing the validity of an ELISA test for the serological diagnosis of human fascioliasis in different epidemiological situations. Trop Med Int Health 2012; 17: 630-636. https://doi.org/10.1111/j.1365-3156.2012.02964.x
  20. Suhardono, Roberts JA, Copeman DB. Variations in the survival of Fasciola gigantica eggs in bovine dung stored in the sun as opposed to the shade. Trop Anim Health Prod 2006; 38: 379-382. https://doi.org/10.1007/s11250-006-4311-x
  21. Ai L, Dong SJ, Zhang WY, Elsheikha HM, Mahmmod YS, Lin RQ, Yuan ZG, Shi YL, Huang WY, Zhu XQ. Specific PCR-based assays for the identification of Fasciola species: their development, evaluation and potential usefulness in prevalence surveys. Ann Trop Med Parasitol 2010; 104: 65-72. https://doi.org/10.1179/136485910X12607012373713
  22. Luton K, Walker D, Blair D. Comparisons of ribosomal internal transcribed spacers from two congeneric species of flukes (Platyhelminthes: Trematoda: Digenea). Mol Biochem Parasitol 1992; 56: 323-327. https://doi.org/10.1016/0166-6851(92)90181-I
  23. Bowles J, Blair D, McManus DP. Genetic variants within the genus Echinococcus identified by mitochondrial DNA sequencing. Mol Biochem Parasitol 1992; 54: 165-173. https://doi.org/10.1016/0166-6851(92)90109-W
  24. Soliman MF. Epidemiological review of human and animal fascioliosis in Egypt. J Infect Dev Ctries 2008; 2: 182-189.
  25. Saba R, Korkmaz M, Inan D, Mamikoglu L, Turhan O, Gunseren F, Cevikol C, Kabaalioglu A. Human fascioliosis. Clin Microbiol Infect 2004; 10: 385-387. https://doi.org/10.1111/j.1469-0691.2004.00820.x
  26. Dauchy FA, Vincendeau P, Lifermann F. Eight cases of fascioliosis: clinical and microbiological features. Med Mal Infect 2006; 36: 42-46. https://doi.org/10.1016/j.medmal.2005.10.005
  27. Pavlovic M, Dakic Z, Milosevic B, Korac M, Brmbolic B, Dzamic A. Human case of fasciolosis in Serbia treated with triclabendazole. Vojnosanit Pregl 2014; 71: 202-206. https://doi.org/10.2298/VSP1402202P
  28. Kozat S, Denizhan V. Glucose, lipid, and lipoprotein levels in sheep naturally infected with Fasciola hepatica. J Parasitol 2010; 96: 657-659. https://doi.org/10.1645/GE-2104.1
  29. Mas-Coma S, Bargues MD, Valero MA. Diagnosis of human fascioliasis by stool and blood techniques: update for the present global scenario. Parasitology 2014; 141: 1918-1946. https://doi.org/10.1017/S0031182014000869
  30. Espino AM, Diaz A, Perez A, Finlay CM. Dynamics of antigenemia and coproantigens during a human Fasciola hepatica outbreak. J Clin Microbiol 1998; 36: 2723-2726.
  31. Pagola Serrano MA, Vega A, Ortega E, Gonzales A. Computed tomography of hepatic fascioliosis. J Comput Assist Tomog 1987; 11: 269-272. https://doi.org/10.1097/00004728-198703000-00014
  32. Patel NU, Bang TJ, Dodd GD 3rd. CT findings of human Fasciola hepatica infection: case reports and review of the literature. Clin Imaging 2016; 40: 251-255. https://doi.org/10.1016/j.clinimag.2015.11.002
  33. Roig GV. Hepatic fascioliasis in the Americas: a new challenge for therapeutic endoscopy. Gastrointest Endosc 2002; 56: 315-317. https://doi.org/10.1016/S0016-5107(02)70203-4
  34. Marcos LA, Tagle M, Terashima A, Bussalleu A, Ramirez C, Carrasco C, Valdez L, Huerta-Mercado J, Freedman DO, Vinetz JM, Gotuzzo E. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fasciolosis. Am J Trop Med Hyg 2008; 78: 222-227.

Cited by

  1. Dynamics of liver enzymes in rabbits experimentally infected with Fasciola sp. (Intermediate form from Japan) vol.80, pp.1, 2017, https://doi.org/10.1292/jvms.17-0315
  2. New insight into genetic variation and haplotype diversity of Fasciola hepatica from Algeria vol.118, pp.4, 2017, https://doi.org/10.1007/s00436-019-06270-5
  3. Letter to the editor discussing the article “curved tunnel’ sign on MRI: a typical radiological feature in hepatic trichinellosis” vol.46, pp.9, 2021, https://doi.org/10.1007/s00261-021-03117-5
  4. Extracellular vesicles from Fasciola gigantica induce cellular response to stress of host cells vol.231, pp.None, 2017, https://doi.org/10.1016/j.exppara.2021.108173